Abstract
Active uptake by „Kälteerythrocyten“ (i.e., human erythrocytes stored at 4 °C for 5–8 days) of photometrically measured potassium has been demonstrated to be inhibited by the cardiac glycosides (c.g.), k-strophanthoside, and digitoxin and their aglucons (Schatzmann, 1953). The drug concentrations necessary to yield this effect ranged from 0.1 µg/ml to 10µg/ml. This effect was shown to be due to an inhibition of membrane Na+-K+-ATPase activity (Post et al., 1960; Dunham and Glynn, 1961; Glynn, 1957).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersson, K.-E., Bertler, A., Redfors, A.: In vitro stability of proscillaridin A. Eur. J. Clin. Pharmacol. 8, 135–139 (1975a)
Andersson, K.-E., Bertler, A., Redfors, A.: On the pharmacokinetics of proscillaridin A in man. Eur. J. Clin. Pharmacol. 8, 421–425 (1975b)
Andersson, K.-E., Bergdahl, B., Bertler, A., Redfors, A.: On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects. Acta Pharmacol. Toxicol. (Kbh.) 40, 153–160 (1977a)
Andersson, K.-E., Bergdahl, B., Dencker, H., Wettrell, G.: Activities of proscillaridin A in thoracic duct lymph after single oral doses in man. Acta Pharmacol. Toxicol. (Kbh.) 40, 280–284 (1977b)
Andersson, K.-E., Bergdahl, B., Wettrell, G.: Biliary excretion and enterohepatic recycling of proscillaridin A after oral administration to man. Eur. J. Clin. Pharmacol. 11, 273–276 (1977c)
Andersson, K.-E., Bergdahl, B., Dencker, H., Wettrell, G.: Proscillaridin activity in portal and peripheral venous blood after oral administration to man. Eur. J. Clin. Pharmacol. 11, 277–281 (1977d)
Beckmann, H., Belz, G.G., Quellhorst, E.: Die Eliminationsgeschwindigkeit von Meproscillarin nach wiederholter Applikation bei Patienten mit eingeschränkter Nierenfunktion. Arzneim. Forsch. 28, 565–567 (1978)
Beckmann H., Belz, G.G., Quellhorst, E.: Wirkung und Plasmakonzentration von Meproscillarin unter Daueranwendung bei Niereninsuffizienz mit gleichzeitig vorliegender Herzinsuffizienz. Med. Klin. 74, 1761–1766 (1979)
Belz, G.G.: Plasma concentrations of intravenous ß-methyl digoxin with and without oral charcoal. Klin. Wochenschr. 52, 749–750 (1974)
Belz, G.G., Bader, H.: Effect of oral charcoal on plasma levels of intravenous methyl proscillaridin. Klin. Wochenschr. 52, 1134–1135 (1974)
Belz, G.G., Belz, G.: Untersuchungen zur Pharmakokinetik von Meproscillarin. Arzneim. Forsch. 28, 535–539 (1978)
Belz, G.G., Belz, G.: Bestimmung der Digitoxin-Serumkonzentration mit einem Solid-Phase ELISA. Med. Klin. 74, 620–623 (1979)
Belz, G.G., Brech, W.J.: Plasmaspiegel und Kumulationsverhalten von Proscillaridin bei Niereninsuffizienz. Klin. Wochenschr. 52, 640–644 (1974)
Belz, G.G., Erbel, R.: Na+-K+-ATPase Assay und 86Rb-Erythrozyten-Assay zum Nachweis von Digitoxin. In: Digitoxin. Greeff, K., Rietbrock, N. (eds.), pp. 13–20. Stuttgart, New York: Schattauer 1979
Belz, G.G., Heinz, N.: The influence of polar and nonpolar digoxin and digitoxin metabolites on the 86Rb-uptake of human erythrocytes and the contractility of guinea pig papillary muscels. Arzneim. Forsch. 27, 653–655 (1977)
Belz, G.G., Kleeberg, U.R.: Inhibition of Na+-K+-ATPase and 86Rb-uptake by Canrenone. Horm. Metab. Res. 5, 312 (1973)
Belz, G.G., Nübling, H.: Half life in plasma following repetitive applications of ß-acetyl digoxin in man. Klin. Wochenschr. 53, 543–544 (1975)
Belz, G.G., Schreiter, H.: Influence of plasma on the glycoside induced inhibition of 86Rbuptake of human erythrocytes. Z. Kardiol. 63, 475–479 (1974)
Belz, G.G., Vollmer, K.O., Wissler, J.H.: Zur Hemmwirkung von Herzglykosiden auf die 86Rb-Aufnahme der Erythrocyten. I. Methodische Untersuchungen zur Konzentrationsbestimmung von Cymarin und Digitoxin. Eur. J. Clin. Pharmacol. 4, 92–98 (1972)
Belz, G.G., Stauch, M., Belz, G., Kurbjuweit, H.G., Oberdorf, A.: The effect of various cardenolides and bufadienolides with different cardiac activity on the 86Rb-uptake of human erythrocytes. Naunyn Schmiedebergs Arch. Pharmacol. 280, 353–362 (1973)
Belz, G.G., Nübling, H., Schmidt-Wiederkehr, P., Franz, H.E.: Plasmakonzentrationen und Elimination von Methylproscillaridin bei Niereninsuffizienz. Klin. Wochenschr. 52, 1078–1081 (1974a)
Belz, G.G., Rudofsky, G., Belz, G.: Glykosidplasmaspiegel und Elektrokardiogramm während mittelschneller und langsamer Sättigung mit ß-Methyldigoxin bei gesunden Probanden. Dtsch. Med. Wochenschr. 99, 329–332 (1974b)
Belz, G.G., Rudofsky, G., Lossnitzer, K., Wolf, G., Stauch, M.: Plasmaspiegel und Elektrokardiogramm nach intravenöser Applikation von Proscillaridin und Digoxin. Z. Kardiol. 63, 201–211 (1974c)
Belz, G.G., Stauch, M., Rudofsky, G.: Plasma levels after a single oral dose of proscillaridin. Eur. J. Clin. Pharmacol. 7, 95–97 (1974d)
Belz, G.G., Nübling, H., Belz, G.: Plasma concentrations during repetitive intravenous and oral methyl proscillaridin application in man. Arzneim. Forsch. 26, 277–278 (1976a)
Belz, G.G., Schreiter, H., Wolf, G.: Studies on pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man. Eur. J. Clin. Pharmacol. 10, 101–108 (1976b)
Belz, G.G., Erbel, R., Schumann, K., Gilfrich, H.J.: Dose-response relationships and plasma concentrations of digitalis glycosides in man. Eur. J. Clin. Pharmacol. 13, 103–111 (1978)
Bergdahl, B., Andersson, K.E.: Stability in vitro of methyl proscillaridin. Eur. J. Clin. Pharmacol. 11, 267–271 (1977)
Bertler, A., Redfors, A.: An improved method of estimating digoxin in human plasma. Clin. Pharmacol. Ther. 11, 665–673 (1970)
Bertler, A., Redfors, A.: The 86Rb method for digoxin assay. Comparison with radioimmunoassay. In.: Symposium on digitalis. Storstein, O. (ed.), pp. 64–70. Oslo: Gyldendal Norsk Forlag 1973
Bertler, A., Monti, M., Ohlin, P., Redfors, A.: Cardiac arrhythmias, electrolytes and digoxin concentration in plasma and urine in patients treated with digoxin. Acta Med. Scand. 197, 391–401 (1975)
Binnion, P.F., Morgan, L.M., Stevenson, H.M., Fletcher, E.: Plasma and myocardial digoxin concentrations in patients on oral therapy. Br. Heart J. 31, 636–640 (1969)
Doering, W., Belz, G.G.: Quinidine-digoxin interaction: Effect of quinidine on 86Rb-uptake of human erythrocytes. Klin. Wochenschr. 59, 95–96 (1981)
Dunham, E.T., Glynn, I.M.: Adenosintriphosphatase activity and the active movements of alkali metal ions. J. Physiol. London 156, 274–293 (1961)
Gjerdrum, K.: Determination of digitalis in blood. Acta Med. Scand. 187, 371–379 (1970)
Gjerdrum, K.: Digitoxin studies. Acta Med. Scand. 191, 25–34 (1972)
Glynn, I.M.: The action of cardiac glycosides on sodium and potassium movements in human red cells. J. Physiol. London 136, 148–173 (1957)
Grahame-Smith, D.G., Aronson, J.K.: Assessment of digoxin action by a pharmacodynamie biochemical method. In: Cardiac glycosides. Bodem, G., Dengler, H.J. (eds.), p. 242. Berlin, Heidelberg, New York: Springer 1978
Grahame-Smith, D.G., Everest, M.S.: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication. Br. Med. J. 1969, 286–289
Haustein, K.O.: Measurement of plasma glycoside level following pengitoxin administration. Eur. J. Clin. Pharmacol. 13, 389–391 (1978)
Hillestad, L., Hansteen, V., Hatle, L. et al: Digitalis intoxication. In: Symposium on Digitalis, Oslo, Norway. Storstein, O. (ed.), pp. 281–286. February 22–23. Oslo: Gyldendal Norsk Forlag 1973
Hoffman, J.F.: The red cell membrane and the transport of sodium and potassium. Am. J. Med. 41, 660 (1966)
Kleeberg, U.R., Belz, G.G.: Die Hemmung der Na+K+-Membran-ATPase und der 86RbAufnahme menschlicher Erythrozyten durch Spironolacton und seine Derivate. Verh. Dtsch. Ges. Inn. Med. 80, 1521–1523 (1974)
Lader, S., Bye, A., Marsden, P.: The measurement of plasma digoxin concentration: A comparison of two methods. Eur. J. Clin. Pharmacol. 5, 22–27 (1972)
Love, W.D., Burch, G.E.: A comparison of potassium42, rubidium86, and cesium134 as tracers of potassium in the study of cation metabolism of human erythrocytes in vitro. J. Lab. Clin. Med. 41, 351–362 (1953)
Lowenstein, J.M.: A method for measuring plasma levels of digitalis glycosides. Circulation 31, 228–233 (1965)
Lowenstein, J.M., Corrill, E.M.: An improved method for measuring plasma and tissue concentrations of digitalis glycosides. J. Lab. Clin. Med. 67, 1048–1052 (1966)
Post, R.L., Merrit, C.R., Kinsolving, C.R., Albright, C.D.: Membrane adenosine triphosphatase as a participant in the active transport of sodium and potassium in the human erythrocytes. J. Biol. Chem. 235, 1796–1802 (1960)
Rasmussen, K., Jervell, J., Storstein, O.: Clinical use of a bio-assay of serum digitoxin activity. Eur. J. Clin. Pharmacol. 3, 236–242 (1971)
Ritzmann, L.W., Bangs, C.C., Coiner, D., Custis, J.M., Walsh, J.R.: Serum glycoside levels by rubidium assay. Arch. Intern. Med. 132, 823–830 (1973)
Rupp, M., Brass, H., Belz, G.G.: Die Hämoperfusion zur Elimination von Meproscillarin. Arzneim. Forsch. 28, 567–569 (1978)
Schatzmann, H.J.: Herzglykoside als Hemmstoffe für den aktiven Kalium-und Natrium‑ transport durch die Erythrozytenmembran. Hely. Physiol. Acta 11, 346–354 (1953)
Shapiro, W., Narahara, K., Taubert, K.: Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man. Circulation 42,1065–1072 (1970)
Somogyi, G., Kâldor, A., Jankovics, A., Faix, L.: Studies of the digitalis level of the cerebrospinal fluid. The effect of digitalis glycosides on the nervous system. Int. J. Clin. Pharmacol. 4, 421–423 (1971)
Twittenhoff, W.D., Brittinger, W.D., Deckert, D.W., Belz, G.G., Schubert, I.: Zur Frage der Kumulation von Meproscillarin bei Niereninsuffizienz. Arzneim. Forsch. 28, 563-565 (1978)
Vollmer, K.O., Wissler, J.H., Belz, G.G.: Zur Hemmwirkung von Herzglykosiden auf die 86Rb-Aufnahme der Erythrocyten. II. Spezifität der Hemmwirkung unter besonderer Berücksichtigung der Cymarin-Reihe. Eur. J. Clin. Pharmacol. 4, 99–103 (1972)
Wilson, B.J. (ed.): The radiochemical manual, 2 nd ed. Amersham: Radiochemical Centre 1966
Wissler, J.H., Belz, G.G., Vollmer, K.O.: Zur Hemmwirkung von Herzglykosiden auf die 86Rb-Aufnahme der Erythrozyten. III. Über die BeeinfluBbarkeit der durch Cymarin bewirkten 86Rb-Aufnahmehemmung der Erythrozyten. Eur. J. Clin. Pharmacol. 4, 104-106 (1972)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Belz, G.G. (1981). Rubidium Uptake in Erythrocytes. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68163-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-68163-9_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68165-3
Online ISBN: 978-3-642-68163-9
eBook Packages: Springer Book Archive